Free Trial

Zepp Health (NYSE:ZEPP) Shares Gap Down - Here's Why

Zepp Health logo with Medical background

Key Points

  • Zepp Health (NYSE:ZEPP) shares experienced a significant drop, opening at $38.10 compared to a previous closing price of $43.48.
  • A recent analysis set a price target of $13.87 for Zepp Health, while the company maintains a consensus "Buy" rating among analysts.
  • In its latest earnings report, Zepp Health posted a negative earnings per share (EPS) of ($1.13), alongside a negative net margin of 38.81%.
  • Looking to export and analyze Zepp Health data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report) shares gapped down before the market opened on Tuesday . The stock had previously closed at $43.48, but opened at $38.10. Zepp Health shares last traded at $39.06, with a volume of 488,811 shares changing hands.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on ZEPP. Fundamental Research set a $13.87 price objective on shares of Zepp Health and gave the company a "buy" rating in a report on Tuesday, April 22nd. Wall Street Zen raised shares of Zepp Health to a "hold" rating in a report on Saturday. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus target price of $13.87.

View Our Latest Stock Analysis on Zepp Health

Zepp Health Stock Performance

The company has a debt-to-equity ratio of 0.31, a current ratio of 1.10 and a quick ratio of 0.78. The company has a market capitalization of $564.99 million, a PE ratio of -8.07 and a beta of 1.11. The firm's fifty day simple moving average is $11.88 and its 200 day simple moving average is $5.95.

Zepp Health (NYSE:ZEPP - Get Free Report) last posted its quarterly earnings results on Monday, May 19th. The company reported ($1.13) EPS for the quarter. Zepp Health had a negative net margin of 38.81% and a negative return on equity of 24.19%. The business had revenue of $38.54 million during the quarter.

Zepp Health Company Profile

(Get Free Report)

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zepp Health Right Now?

Before you consider Zepp Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.

While Zepp Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines